Debt-to-equity of REVELATION BIOSCIENCES, INC. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
REVELATION BIOSCIENCES, INC. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • REVELATION BIOSCIENCES, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 27%, a 78% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

REVELATION BIOSCIENCES, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 27% -97% -78% 31 Dec 2025
Q3 2025 29% -102% -78% 30 Sep 2025
Q2 2025 61% -43% -41% 30 Jun 2025
Q1 2025 160% +102% +179% 31 Mar 2025
Q4 2024 124% +60% +93% 31 Dec 2024
Q3 2024 130% +58% +81% 30 Sep 2024
Q2 2024 105% +18% +20% 30 Jun 2024
Q1 2024 57% -143% -71% 31 Mar 2024
Q4 2023 64% -1647% -96% 31 Dec 2023
Q3 2023 72% -10957% -99% 30 Sep 2023
Q2 2023 87% -1330% -94% 30 Jun 2023
Q1 2023 200% -30% -13% 31 Mar 2023
Q4 2022 1711% +1605% +1524% 31 Dec 2022
Q3 2022 11030% +10922% +10152% 30 Sep 2022
Q2 2022 1417% +1305% +1170% 30 Jun 2022
Q1 2022 230% 31 Mar 2022
Q4 2021 105% 31 Dec 2021
Q3 2021 108% 30 Sep 2021
Q2 2021 112% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.